Gts Securities LLC Bausch Health Companies Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$5.22 - $8.26 $172,260 - $272,580	-33,000 Reduced 67.9%	15,600 $127,000
Q2 2024 Aug 14, 2024	SELL	$6.1 - $10.41 $139,080 - $237,348	-22,800 Reduced 31.93%	48,600 $338,000
Q1 2024 May 15, 2024	SELL	$7.77 - $10.61 $2.5 Million - $3.42 Million	-322,200 Reduced 81.86%	71,400 $757,000
Q4 2023 Feb 14, 2024	BUY	$6.53 - $8.23 $967,746 - $1.22 Million	148,200 Added 60.39%	393,600 $3.16 Million
Q3 2023 Nov 15, 2023	BUY	$7.69 - $9.71 $1.89 Million - $2.38 Million	245,400 New	245,400 $2.02 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.